TRi-1
CAS No. 246020-68-8
TRi-1 ( —— )
Catalog No. M20217 CAS No. 246020-68-8
TRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 86 | In Stock |
|
5MG | 132 | In Stock |
|
10MG | 205 | In Stock |
|
25MG | 340 | In Stock |
|
50MG | 484 | In Stock |
|
100MG | 700 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTRi-1
-
NoteResearch use only not for human use.
-
Brief DescriptionTRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
-
DescriptionTRi-1 is irreversible inhibitor of?cytosolic thioredoxin reductase 1 (TXNRD1) with an?IC50?of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTXNRD1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number246020-68-8
-
Formula Weight328.72
-
Molecular FormulaC12H9ClN2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL?(190.13 mM)
-
SMILESCOc1ccc(c(n1)S(=O)(=O)c1ccc(Cl)cc1)[N+]([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stafford WC et al. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med. 2018 Feb 14;10(428). pii: eaaf7444.
molnova catalog
related products
-
16beta-Methyl-16alph...
——
-
trans-AUCB
trans-AUCB is an effective and selective soluble epoxide hydrolase inhibitor.
-
Rhodojaponin V
Antibacterial; anti-inflammatory.